Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 1/20 | 0.34 |
| ▸ | CTSK | P43235 | 1/20 | 0.34 |
| ▸ | PSEN1 | P49768 | 6/20 | 0.33 |
| ▸ | PSEN2 | P49810 | 6/20 | 0.33 |
| ▸ | APH1B | Q8WW43 | 6/20 | 0.33 |
| ▸ | NCSTN | Q92542 | 6/20 | 0.33 |
| ▸ | APH1A | Q96BI3 | 6/20 | 0.33 |
| ▸ | PSENEN | Q9NZ42 | 6/20 | 0.33 |
| ▸ | FPR2 | P25090 | 1/20 | 0.32 |
| ▸ | CTSC | P53634 | 1/20 | 0.32 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7175773 | 0.79 | NOD1 (0.49) | FPR2NOD1SLC6A5 | |
| SCHEMBL12229210 | 0.79 | KDM4E (0.39) | CTSSCTSKPSEN1PSEN2APH1B | |
| SCHEMBL7175771 | 0.79 | NOD1 (0.49) | FPR2NOD1SLC6A5 | |
| SCHEMBL23792690 | 0.79 | NOD1 (0.34) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL18438964 | 0.78 | CTSK (0.43) | CTSSCTSKL3MBTL1 | |
| SCHEMBL18438966 | 0.78 | CTSK (0.43) | CTSSCTSKL3MBTL1 | |
| SCHEMBL25474945 | 0.78 | NOD1 (0.33) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL12598695 | 0.76 | CTSK (0.44) | CTSSCTSKPSEN1PSEN2APH1B | |
| SCHEMBL7802720 | 0.73 | HDAC7 (0.34) | CTSSCTSKPSEN1PSEN2APH1B | |
| SCHEMBL12250669 | 0.73 | HDAC7 (0.34) | CTSSCTSKPSEN1PSEN2APH1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159594-A1 | COMPOUNDS FOR USE IN VIRAL INFECTIONS | PHARMA MAR, S.A. (ES) | 2023-05-25 | — | — | US | disclosed |
| US-20230159594-A1 | COMPOUNDS FOR USE IN VIRAL INFECTIONS | PHARMA MAR, S.A. (ES) | 2023-05-25 | — | — | US | disclosed |
| US-20230158102-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF CORONAVIRUS INFECTION | PHARMA MAR, S.A. (ES) | 2023-05-25 | — | — | US | disclosed |
| US-20230158102-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF CORONAVIRUS INFECTION | PHARMA MAR, S.A. (ES) | 2023-05-25 | — | — | US | disclosed |
| US-20230158104-A1 | COMPOUNDS FOR USE IN AUTOIMMUNE CONDITIONS | PHARMA MAR, S.A. (ES) | 2023-05-25 | — | — | US | disclosed |
| US-20230158104-A1 | COMPOUNDS FOR USE IN AUTOIMMUNE CONDITIONS | PHARMA MAR, S.A. (ES) | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230158102-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF CORONAVIRUS INFECTION | ACE, SARS1, ACE2 | CTSS 402/4885CTSK 566/4885PSEN1 616/4885 |
| US-20230159594-A1 | COMPOUNDS FOR USE IN VIRAL INFECTIONS | OAT, MAVS, HAVCR2 | CTSS 1320/4885CTSK 2187/4885PSEN1 1735/4885 |
| US-20230158104-A1 | COMPOUNDS FOR USE IN AUTOIMMUNE CONDITIONS | SSB, HLA-DRB1, TPMT | CTSS 1910/4885CTSK 1124/4885PSEN1 4280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.